Dr. Addison R. Tolentino
Claim this profileSaint Luke's Hospital of Kansas City
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
14 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Addison R. Tolentino is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Addison R. Tolentino
Clinical Trial Related10 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Addison R. Tolentino has experience with
- Pembrolizumab
- Carboplatin
- Axillary Lymph Node Dissection (ALND)
- Nodal Radiation Therapy
- Axillary Radiation Therapy
- Biospecimen Collection
Breakdown of trials Addison R. Tolentino has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Addison R. Tolentino specialize in?
Addison R. Tolentino focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Addison R. Tolentino currently recruiting for clinical trials?
Yes, Addison R. Tolentino is currently recruiting for 3 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Addison R. Tolentino has studied deeply?
Yes, Addison R. Tolentino has studied treatments such as Pembrolizumab, Carboplatin, Axillary Lymph Node Dissection (ALND).
What is the best way to schedule an appointment with Addison R. Tolentino?
Apply for one of the trials that Addison R. Tolentino is conducting.
What is the office address of Addison R. Tolentino?
The office of Addison R. Tolentino is located at: Saint Luke's Hospital of Kansas City, Kansas City, Missouri 64111 United States. This is the address for their practice at the Saint Luke's Hospital of Kansas City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.